CRSP
Crispr Therapeutics AG
50.40$
-3.6%
vs. previous close
Closing price · As of: Oct 8, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 16 | Q4 16 | Q1 17 | Q2 17 | Q3 17 | Q4 17 | Q1 18 | Q2 18 | Q3 18 | Q4 18 | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | – | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 778.1% | 664.3% | 547.7% | 477.9% | 747.6% | 62.0% | 1,437.3% | 2,356.0% | 7,072.8% | 25,044.3% | 8,798.8% | 12,431.8% | 27.0% | 63.3% | 34,517.8% | 134,954.5% | 47,978.4% | 22,260.8% | 9,873.8% | 3.0% | 6,828.0% | 1,046.0% | 17,216.9% | 21,469.6% | 41,339.4% | 113,716.7% | 42.2% | 63.8% | – | 10.0% | 10,277.6% | 11,020.5% | 2,650.0% | 11.9% | 6,648.4% | 5,577.7% | 7,277.1% | 6,870.8% | 3,446.4% | 437.8% | 1,634.4% | |
| -678.1% | -564.3% | -447.7% | -377.9% | -647.6% | 38.0% | -1,337.3% | -2,256.0% | -6,972.8% | -24,944.3% | -8,698.8% | -12,331.8% | 73.0% | 36.7% | -34,417.8% | -134,854.5% | -47,878.4% | -22,160.8% | -9,773.8% | 97.0% | -6,728.0% | -946.0% | -17,116.9% | -21,369.6% | -41,239.4% | -113,616.7% | 57.8% | 36.2% | – | 90.0% | -10,177.6% | -10,920.5% | -2,550.0% | 100.0% | -6,548.4% | -5,477.7% | -7,177.1% | -6,770.8% | -3,346.4% | -337.8% | -1,534.4% | |
| 778.1% | 664.3% | 547.7% | 477.9% | 747.6% | 62.0% | 1,437.3% | 2,356.0% | 7,072.8% | 25,044.3% | 10,311.6% | 12,431.8% | 27.0% | 63.3% | 34,517.8% | 134,954.5% | 47,978.4% | 22,260.8% | 34,960.4% | 9.1% | 25,379.9% | 799.2% | 66,429.8% | 77,989.2% | 124,066.0% | 1,725,916.7% | 99.9% | 145.1% | – | 47.6% | 14,154.6% | 14,568.7% | 12,850.5% | 234.7% | 8,379.7% | 7,320.0% | 6,625.6% | 9,012.2% | 4,703.3% | 638.0% | 2,018.3% | |
| 265.1% | 515.4% | 319.7% | 216.9% | 339.8% | 35.0% | 650.7% | 1,171.0% | 1,807.3% | 14,384.3% | 4,551.5% | 4,958.5% | 7.3% | 22.4% | 12,452.2% | 48,529.5% | 14,553.4% | 6,963.8% | 12,137.1% | 3.2% | 7,206.4% | 183.6% | 15,742.1% | 16,628.5% | 28,724.5% | 352,816.7% | 22.4% | 27.2% | – | 8.2% | 3,562.1% | 3,768.1% | 2,893.5% | 51.8% | 2,230.8% | 2,120.6% | 1,904.5% | 2,129.5% | 1,178.5% | 172.4% | 523.2% | |
| 1,043.2% | 1,179.8% | 867.4% | 694.8% | 1,087.4% | 97.0% | 2,088.0% | 3,527.0% | 8,880.1% | 39,428.7% | 14,863.1% | 17,390.3% | 34.3% | 22.4% | 12,452.2% | 48,529.5% | 14,553.4% | 6,963.8% | 46,930.7% | 12.3% | 32,435.9% | 183.6% | 81,743.8% | 94,617.7% | 152,790.4% | 2,078,733.3% | 122.3% | 172.3% | – | 55.2% | 17,716.7% | 18,336.8% | 15,744.0% | 284.5% | 10,610.4% | 9,440.6% | 7,677.7% | 11,141.7% | 5,586.9% | 789.8% | 2,437.1% | |
| -943.2% | -1,079.8% | -767.4% | -594.8% | -987.4% | 3.0% | -1,988.0% | -3,427.0% | -8,780.1% | -39,328.7% | -14,763.1% | -17,290.3% | 65.7% | 14.3% | -46,870.1% | -183,384.1% | -62,431.8% | -29,124.6% | -56,704.5% | 84.7% | -39,163.8% | -1,129.5% | -98,860.7% | -115,987.3% | -194,029.8% | -2,192,350.0% | -64.5% | -136.0% | – | 34.8% | -27,894.2% | -29,257.3% | -18,294.0% | -184.5% | -17,158.8% | -14,918.3% | -14,854.8% | -17,912.5% | -8,933.3% | -1,127.6% | -3,971.5% | |
| 0.1% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | – | – | – | – | – | – | – | – | – | – | – | – | 203.9% | 6,843.7% | 7,727.7% | 288,933.3% | 17.8% | – | – | 8.9% | – | – | – | – | – | – | – | – | – | – | – | |
| -948.1% | 746.5% | -784.2% | -613.4% | -1,005.4% | 1.7% | -2,077.6% | -3,518.8% | -8,982.9% | -41,179.1% | -14,732.6% | -16,859.7% | 65.4% | 39.7% | -44,174.5% | -180,175.0% | -62,323.6% | -28,889.7% | -55,736.6% | 84.8% | -38,829.2% | -1,077.6% | -98,656.7% | -113,744.3% | -186,302.1% | -2,000,850.0% | -51.7% | -109.7% | – | 44.8% | -22,989.5% | -24,201.4% | -14,130.6% | -104.6% | -15,593.9% | -23,235.1% | -11,903.5% | -15,046.2% | -8,373.9% | -885.9% | -3,346.1% | |
| 0.5% | 17.1% | 10.3% | 9.6% | 29.6% | 1.3% | 6.3% | 8.8% | 24.3% | 203.5% | 25.9% | 26.7% | 0.1% | 0.0% | 240.1% | 861.4% | 135.1% | 39.7% | 284.7% | 0.5% | -180.9% | 17.5% | 2,027.0% | 3,872.2% | -611.7% | -157,933.3% | 1.3% | 1.3% | – | 0.1% | 143.7% | 248.9% | 145.5% | 2.0% | 128.2% | 144.8% | 69.6% | 71.1% | 57.5% | 9.4% | 22.6% | |
| -948.6% | 729.4% | -794.5% | -623.0% | -1,035.1% | 0.4% | -2,083.9% | -3,527.6% | -9,007.3% | -41,382.6% | -14,758.5% | -16,886.5% | 65.3% | 39.7% | -44,414.6% | -181,036.4% | -62,458.8% | -28,929.5% | -56,021.3% | 84.3% | -38,648.3% | -1,095.0% | -100,683.7% | -117,616.5% | -185,690.4% | -1,842,916.7% | -53.1% | -111.1% | – | 44.7% | -23,133.1% | -24,450.3% | -14,276.1% | -106.6% | -15,722.1% | -23,379.9% | -11,973.1% | -15,117.2% | -8,431.5% | -895.3% | -3,368.7% | |
| -932.8% | -976.9% | -740.8% | -575.1% | -954.3% | 5.5% | -1,927.2% | -3,347.5% | -8,623.3% | -44,379.1% | -14,515.5% | -16,913.5% | 66.3% | 16.1% | -45,538.2% | -178,402.3% | -60,854.1% | -28,431.1% | -55,360.4% | 85.2% | -37,210.9% | -1,029.0% | -95,264.0% | -109,143.7% | -180,963.8% | -1,903,416.7% | -46.7% | -102.7% | – | 47.2% | -22,030.6% | -23,264.2% | -13,343.4% | -90.8% | -15,046.4% | -22,719.4% | -11,404.8% | -14,391.0% | -8,077.7% | -1,085.5% | -3,390.2% |
LTM = last twelve months (sum of the four most recent quarters).
Showing the most recent 40 periods — older statements are on file for this stock.
Data as of: October 8, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.